January 3, 2020 08:57 AM EST
News Briefing

Bank­rupt uBio­me sells off patents, da­ta for $7M; J&J buys op­tions on Pul­ma­trix's lung can­cer drugs

Amber Tong

→ In the fi­nal chap­ter of dis­graced gut test­ing play­er uBio­me’s sto­ry, Pso­ma­gen has ac­quired all its key as­sets in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Broad In­sti­tute pa­per of­fers po­ten­tial new frame­work for treat­ing Hunt­ing­ton’s dis­ease

FDA re­jects Atara's cell ther­a­py for rare trans­plant com­pli­ca­tion, stock craters

Roche's car­diometa­bol­ic chief warns against weight loss 'ob­ses­sion' with GLP-1s

HHS blasts Boehringer's drug price case, re­veals new de­tails on Jar­diance talks

De­part­ing FDA com­mis­sion­er: 'We're los­ing the bat­tle on mis­in­for­ma­tion'

Boehringer's schiz­o­phre­nia as­set fails Phase 3; GSK buys organoid biotech

A service from the Financial Times